Elena Kaschina

Hessische Str. 3-4
Berlin, BE 10115, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

The Role of Endothelial-Mesenchymal Transition (EndMT) in Aneurysm Formation.

The Role of Endothelial-Mesenchymal Transition (EndMT) in Aneurysm Formation.

Journal: Biomedicines

Published: June 12, 2026

Pro-Inflammatory Activation Promotes Atherogenic Endothelial Phenotype in Male and Female Human Umbilical Endothelial Vein Cells (HUVECs).

Pro-Inflammatory Activation Promotes Atherogenic Endothelial Phenotype in Male and Female Human Umbilical Endothelial Vein Cells (HUVECs).

Journal: International journal of molecular sciences

Published: February 21, 2026

Cross-talk between exercises and renin-angiotensin-aldosterone-system blockade in hypertension.

Cross-talk between exercises and renin-angiotensin-aldosterone-system blockade in hypertension.

Journal: Hypertension research : official journal of the Japanese Society of Hypertension

Published: March 04, 2024

Angiotensin AT2 receptors reduce inflammation and fibrosis in cardiovascular remodeling.

Angiotensin AT2 receptors reduce inflammation and fibrosis in cardiovascular remodeling.

Journal: Biochemical pharmacology

Published: October 05, 2023

Aortic Aneurysm: Finding the Right Target.

Aortic Aneurysm: Finding the Right Target.

Journal: Biomedicines

Published: April 19, 2023

Risk factors for elective and urgent open conversion after EVAR-a retrospective observational study.

Risk factors for elective and urgent open conversion after EVAR-a retrospective observational study.

Journal: Vascular

Published: November 22, 2022

Differential Regulation of MMPs, Apoptosis and Cell Proliferation by the Cannabinoid Receptors CB1 and CB2 in Vascular Smooth Muscle Cells and Cardiac Myocytes.

Differential Regulation of MMPs, Apoptosis and Cell Proliferation by the Cannabinoid Receptors CB1 and CB2 in Vascular Smooth Muscle Cells and Cardiac Myocytes.

Journal: Biomedicines

Published: November 21, 2022

SGLT2 Inhibitor Empagliflozin Modulates Ion Channels in Adult Zebrafish Heart.

SGLT2 Inhibitor Empagliflozin Modulates Ion Channels in Adult Zebrafish Heart.

Journal: International journal of molecular sciences

Published: June 28, 2022

Use of MALDI Mass Spectrometry Imaging to Identify Proteomic Signatures in Aortic Aneurysms after Endovascular Repair.

Use of MALDI Mass Spectrometry Imaging to Identify Proteomic Signatures in Aortic Aneurysms after Endovascular Repair.

Journal: Biomedicines

Published: June 26, 2021

Low-Dose Empagliflozin Improves Systolic Heart Function after Myocardial Infarction in Rats: Regulation of MMP9, NHE1, and SERCA2a.

Low-Dose Empagliflozin Improves Systolic Heart Function after Myocardial Infarction in Rats: Regulation of MMP9, NHE1, and SERCA2a.

Journal: International journal of molecular sciences

Published: April 21, 2021

The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target.

The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target.

Journal: Pharmacological reviews

Published: December 23, 2020

Comparative efficacy of empagliflozin and drugs of baseline therapy in post-infarct heart failure in normoglycemic rats.

Comparative efficacy of empagliflozin and drugs of baseline therapy in post-infarct heart failure in normoglycemic rats.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: January 09, 2020

Showing 1-12 of 27

Last Updated: 09/26/2026